CDC No Longer Recommends COVID-19 Vaccines for All, Leaves Vaccination Choices to Individuals
The CDC has stopped recommending COVID-19 vaccines for all populations, advising individuals to consult healthcare providers for vaccination decisions amid policy shifts and ongoing debates about vaccine safety.
On October 6, 2025, the Centers for Disease Control and Prevention (CDC) announced a significant shift in its COVID-19 vaccination policy. Following recommendations from a newly assembled panel of vaccine advisers, the CDC has ceased to recommend COVID-19 shots for everyone, instead leaving the decision-making process entirely to patients and their healthcare providers.
Historically, U.S. health officials have recommended annual COVID-19 booster shots for all individuals aged 6 months and older, aiming to bolster immunity against the continually evolving virus. This strategy was primarily designed to provide broad protection and reduce severe illness and hospitalizations. As the pandemic subsided, experts increasingly suggested a more targeted approach, focusing on vulnerable populations such as seniors.
However, earlier this year, in May, Health Secretary Robert F. Kennedy Jr., who has publicly questioned vaccine safety, declared that COVID-19 vaccines were no longer recommended for healthy children and pregnant women. He also replaced the CDC’s Advisory Committee on Immunization Practices with a handpicked group of advisers.
The new panel recently advised that Americans should make individual vaccination decisions, emphasizing consulting healthcare professionals like doctors or pharmacists, especially for seniors. Deputy Secretary of Health and Human Services Jim O'Neill, acting as the CDC’s temporary head, endorsed this guidance and signed off on it last week.
The CDC’s move also included calls for stronger language around possible vaccine risks, despite widespread medical consensus supporting the safety and efficacy of COVID-19 vaccines, which have been administered to billions worldwide. Many major medical organizations continue to recommend vaccination for high-risk groups, such as children, pregnant women, and seniors, citing the risks of COVID-19 complications.
This policy change marks a notable departure from previous approaches and underscores a shift toward a more individualized vaccination strategy. It also highlights ongoing debates within public health regarding vaccine safety, risk communication, and the best strategies to protect the population amidst changing circumstances.
Source: https://medicalxpress.com/news/2025-10-cdc-covid-shots-decision-patients.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative AI System Improves Accuracy in Flu Vaccine Strain Selection
A groundbreaking AI system developed at MIT is transforming flu vaccine strain prediction, enabling more accurate and timely vaccine formulation to combat rapidly evolving influenza viruses.
New Insights into Why Immunotherapy Fails and How to Overcome Resistance in Cancer Treatment
New research sheds light on why immunotherapy fails in many cancer patients and introduces promising strategies to overcome treatment resistance by targeting the protein sClever-1, paving the way for more effective cancer therapies.
Michigan Reports Second Measles Outbreak Amid Rising National Cases
Michigan reports its second measles outbreak of 2025 as the US reaches over 1,200 cases nationwide. The resurgence highlights the importance of vaccination to prevent severe complications and curb outbreaks.
Maternal Selenium Levels During Pregnancy May Lower Risk of Childhood Streptococcal Infections
Higher selenium levels during pregnancy may help protect children from streptococcal infections, supporting immune development. Learn more about this significant study from Japan.